<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Verona Pharma plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Verona Pharma plc

    Verona Pharma plc is a clinical stage biopharmaceutical company focused on the development and commercialization of innovative prescription medicines to treat respiratory diseases with significant unmet medical needs, such as COPD, cystic fibrosis and asthma. The Company is listed on the Nasdaq Global Market in the United States under the VRNA ticker and on the London Stock Exchange in the United Kingdom under the VRP.L ticker. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan-Anders Karlsson Ph.D
    • FOUNDED
      2005
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Scottline Healthcare Solutions, Inc

    Scottline Healthcare Solutions, Inc

    Scottline helps healthcare organizations establish a secure, agile digital infrast...

    Scottline helps healthcare organizations establ...

    Filing Type:    RARD
    DarioHealth Corp.

    DarioHealth Corp.

    DarioHealth Corp. (NASDAQ: DRIO) is a leading global Digital Therapeutics (DTx) co...

    DarioHealth Corp. (NASDAQ: DRIO) is a leading g...

    Filing Type:    PU
    Athersys, Inc.

    Athersys, Inc.

    We are an international biotechnology company that is focused in the field of rege...

    We are an international biotechnology company t...

    Filing Type:    PU
    Trevena, Inc.

    Trevena, Inc.

    Trevena is a biopharmaceutical company focused on the development and commercializ...

    Trevena is a biopharmaceutical company focused ...

    Filing Type:    PU
    Forty Seven, Inc.

    Forty Seven, Inc.

    Forty Seven is a clinical-stage immuno-oncology company focused on developing nove...

    Forty Seven is a clinical-stage immuno-oncology...

    Filing Type:    PU
    Marker Therapeutics, Inc.

    Marker Therapeutics, Inc.

    We are a clinical-stage immuno-oncology company specializing in the development an...

    We are a clinical-stage immuno-oncology company...

    Filing Type:    PU
    Adamis Pharmaceuticals Corporation

    Adamis Pharmaceuticals Corporation

    Founded in 2006 and headquartered in San Diego, Adamis (ADMP) is a specialty bioph...

    Founded in 2006 and headquartered in San Diego,...

    Filing Type:    PU
    Itamar Medical Ltd.

    Itamar Medical Ltd.

    Itamar Medical Ltd. is a publicly traded medical device company (TASE:ITMR) based ...

    Itamar Medical Ltd. is a publicly traded medica...

    Filing Type:    PU
    Innoviva, Inc.

    Innoviva, Inc.

    Innoviva, Inc. (NASDAQ: INVA) is focused on royalty management. Innoviva’s portf...

    Innoviva, Inc. (NASDAQ: INVA) is focused on roy...

    Filing Type:    PU
    Regeneron Pharmaceuticals, Inc.

    Regeneron Pharmaceuticals, Inc.

    We are a leading science and technology company that delivers life-transforming me...

    We are a leading science and technology company...

    Filing Type:    PU
    ©2024 National Investor Network. All Rights Reserved.